Biofrontera Stock Rises After Allowance for U.S. Patent on Innovative Illumination Protocol
Biofrontera Inc. (NASDAQ: BFRI) shares spiked more than 35% after the biopharmaceutical company announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the U.S. patent application number 17/234,490, titled “Illumination for Photodynamic Therapy,”...